EML's affirmation of guidance reeks of desperation to me, while the potential revenue shortfall is concerning the bigger question mark here is the risk of systematic issues with EML's AML/CTF approach in other jurisdictions as well as general governance. We have seen what can happen when these growth companies get too big for their boots (Nuix).

The human capital and resources deployed for this as well as shift of management vision to fix this up makes it a sell for me.